Preliminary Results of a Phase II Trial Comparing Outcomes of Patients Transplanted with Lungs from Uncontrolled Donation After Cardiac Death Donors (uDCDDs) Assessed with Ex-vivo Lung Perfusion (EVLP) to Lungs from Conventional Brain-Dead Donors